2Guo RC,Sun RP, Cui X.Distribution of N-acetylate phenotype in Chinese children and its relationship with down's syndrome and duchenne muscular dystrophy.Chin J Clin Pharmacol Ther,1999;4(1):17
3Guo RC,Wolfgang T, Bernhard L.The relationship between high incidence of adverse dapsone reaction in Aids patients and slow acetylator phenotype or low plasma/lymphocytes glutathione level of these patients. Chin Med J (Engl),1996;109(12):933
8Risch A, Wallace DM, athers S, et al. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet,1995; 4(2):231
9Kloth MT, Gee Rl, Messing EM, et al. Expression of NAT in cultured human uroepithelial cells. Carcinogenesis,1994; 15(12):2781
6T. Graf,F. Broly,F. Hoffmann,M. Probst,U. A. Meyer,PD Dr. H. Howald. Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers[J] 1992,European Journal of Clinical Pharmacology(4):399～403
7Y. Horai,K. Fujita,T. Ishizaki. Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer[J] 1989,European Journal of Clinical Pharmacology(6):581～587
